HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension.

Abstract
The present study was performed to determine the effects of neuronal nitric oxide synthase (nNOS) and cyclooxygenase-2 (COX-2) inhibition on blood pressure and renal hemodynamics in transgenic rats with inducible ANG II-dependent malignant hypertension [strain name: TGR(Cyp1a1Ren2)]. Male Cyp1a1-Ren2 rats (n = 7) were fed a normal diet containing indole-3-carbinol (I3C; 0.3%) for 6-9 days to induce malignant hypertension. Mean arterial pressure (MAP) and renal hemodynamics were assessed in pentobarbital sodium-anesthetized Cyp1a1-Ren2 rats before and during intravenous infusion of the nNOS inhibitor S-methyl-l-thiocitrulline (l-SMTC; 1 mg/h). In hypertensive Cyp1a1-Ren2 rats, l-SMTC increased MAP from 169 +/- 3 to 188 +/- 4 mmHg (P < 0.01), which was a smaller increase than in noninduced rats (124 +/- 9 to 149 +/- 9 mmHg, P < 0.01, n = 5). Additionally, l-SMTC decreased renal plasma flow (RPF) to a similar extent (-34 +/- 13 vs. -35 +/- 12%) in the hypertensive and normotensive rats (4.1 +/- 0.2 to 2.7 +/- 0.5 and 3.1 +/- 0.3 to 2.0 +/- 0.3 ml x min(-1) x g(-1), respectively, P < 0.01) but did not alter glomerular filtration rate (GFR) in either group. In additional experiments, administration of the COX-2 inhibitor, nimesulide (3 mg/kg i.v.), during simultaneous infusion of l-SMTC decreased MAP in both hypertensive and noninduced rats (182 +/- 2 to 170 +/- 3 mmHg and 153 +/- 3 to 140 +/- 3 mmHg, respectively, P < 0.01). Nimesulide also decreased RPF (1.9 +/- 0.2 to 0.8 +/- 0.1 ml x min(-1) x g(-1), P < 0.01) and GFR (0.9 +/- 0.1 to 0.4 +/- 0.1 ml x min(-1) x g(-1), P < 0.01) in hypertensive rats but did not alter RPF or GFR in noninduced rats. The present findings demonstrate that both nNOS-derived NO and COX-2 metabolites exert pronounced renal vasodilator influences in hypertensive Cyp1a1-Ren2 rats. The data also indicate that the renal vasodilator effects of COX-2-derived prostanoids in hypertensive Cyp1a1-Ren2 rats are not dependent on nNOS activity.
AuthorsMatthew E Patterson, John J Mullins, Kenneth D Mitchell
JournalAmerican journal of physiology. Renal physiology (Am J Physiol Renal Physiol) Vol. 294 Issue 1 Pg. F205-11 (Jan 2008) ISSN: 1931-857X [Print] United States
PMID17977909 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclooxygenase Inhibitors
  • Enzyme Inhibitors
  • Indoles
  • Ren2 protein, mouse
  • Sulfonamides
  • Angiotensin II
  • Citrulline
  • indole-3-carbinol
  • Nitric Oxide Synthase Type I
  • Cytochrome P-450 CYP1A1
  • Cyclooxygenase 2
  • Renin
  • Thiourea
  • S-methylthiocitrulline
  • nimesulide
Topics
  • Angiotensin II
  • Animals
  • Animals, Genetically Modified
  • Blood Pressure (drug effects, physiology)
  • Citrulline (analogs & derivatives, pharmacology)
  • Cyclooxygenase 2 (metabolism)
  • Cyclooxygenase Inhibitors (pharmacology)
  • Cytochrome P-450 CYP1A1 (genetics, metabolism)
  • Enzyme Inhibitors (pharmacology)
  • Hypertension, Malignant (chemically induced, metabolism)
  • Indoles
  • Kidney (blood supply, drug effects, metabolism)
  • Male
  • Nitric Oxide Synthase Type I (antagonists & inhibitors, metabolism)
  • Rats
  • Regional Blood Flow (drug effects)
  • Renin (genetics, metabolism)
  • Sulfonamides (pharmacology)
  • Thiourea (analogs & derivatives, pharmacology)
  • Vasoconstriction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: